Search - tctmd.com

Displaying 541 - 560 of 1183

Sort: Relevancy | Date

Presentation TCT 2019

Device-Based Autonomic Modulation in Heart Failure

Presenter: Michael Boehm

September 28, 2019

News Opinion Editor's Corner TCT 2019

TCT 2019 Day Three: Thowback Saturday Revisits COAPT, PARTNER 2A, and EXCEL

Shelley Wood

September 28, 2019

Presentation TCT 2019

COAPT: 3-Year Outcomes From a Randomized Trial of the MitraClip in Patients With Heart Failure and Severe Secondary Mitral Regurgitation

Presenter: Michael Mack

September 28, 2019

News Conference News TCT 2019

Surgical Volume Matters When It Comes to Repair of Primary MR

Todd Neale

September 28, 2019

Presentation TCT 2019

Orbital Atherectomy for Coronary Calcification: When and How

Presenter: Richard Shlofmitz

September 28, 2019

News Conference News TCT 2019

Transcatheter Options Best for Tricuspid Regurgitation in Matched Registry Analysis

Michael O'Riordan

September 27, 2019

Presentation TCT 2019

Defining High Bleeding Risk: HBR ARC

Presenter: Philip Urban

September 27, 2019

Presentation TCT 2019

Reimbursement Pathways for Shock Devices

Presenter: Lori Ashby

September 27, 2019

Presentation TCT 2019

Designing Controlled Trials for Shock Devices: Population Targets and Safety and Effectiveness Considerations

Presenter: Anthony Gershlick

September 27, 2019

Presentation TCT 2019

Industry Perspectives on Controlled Trials for Shock Devices

Presenter: Seth Bilazarian

September 27, 2019

Presentation TCT 2019

Devices to Treat Shock: Regulatory Perspectives

Presenter: Fernando Aguel

September 27, 2019

Presentation TCT 2019

TAVR for Bioprosthetic Aortic Valve Failure 2: "To Split or Not to Split" — Case Presentation and Update on the Role of BASILICA to Reduce the Risk of Coronary Obstruction During VIV Procedures

Presenter: Adam Greenbaum

September 27, 2019

Presentation TCT 2019

Perspectives on Infarct Size as a Surrogate in STEMI

Presenter: Navin Kapur

September 27, 2019

Presentation TCT 2019

TAVR for Bioprosthetic Aortic Valve Failure 1: "To Crack or Not to Crack" — Case Presentation and Update on the Role of Fracturing Bioprosthetic Valves During VIV Procedures

Presenter: Adnan Chhatriwalla

September 27, 2019

Presentation TCT 2019

Industry View on Controlled Trials for Heart Failure and Shock Devices

Presenter: William Abraham

September 27, 2019

Presentation TCT 2019

ARC Initiative for Heart Failure and Shock: HF ARC, Shock ARC, and More

Presenter: Christopher O'Connor

September 27, 2019

News Conference News TCT 2019

SCOPE I: Acurate Neo Comes Up Short for Severe Aortic Stenosis

Marcus A. Banks

September 27, 2019

Presentation TCT 2019

Devices for Heart Failure: FDA Perspectives on Trial Designs and Endpoints

Presenter: Bram Zuckerman

September 27, 2019

News Conference News TCT 2019

Learning Curve Exists for MitraClip, Volume-Outcomes Data Hint

Todd Neale

September 27, 2019

Presentation TCT 2019

Role of Heart Failure Specialist in the Post-COAPT World

Presenter: JoAnn Lindenfeld

September 27, 2019

Advertisement

Device-Based Autonomic Modulation in Heart Failure

TCT 2019 Day Three: Thowback Saturday Revisits COAPT, PARTNER 2A, and EXCEL

COAPT: 3-Year Outcomes From a Randomized Trial of the MitraClip in Patients With Heart Failure and Severe Secondary Mitral Regurgitation

Surgical Volume Matters When It Comes to Repair of Primary MR

Orbital Atherectomy for Coronary Calcification: When and How

Transcatheter Options Best for Tricuspid Regurgitation in Matched Registry Analysis

Defining High Bleeding Risk: HBR ARC

Reimbursement Pathways for Shock Devices

Designing Controlled Trials for Shock Devices: Population Targets and Safety and Effectiveness Considerations

Industry Perspectives on Controlled Trials for Shock Devices

Devices to Treat Shock: Regulatory Perspectives

TAVR for Bioprosthetic Aortic Valve Failure 2: "To Split or Not to Split" — Case Presentation and Update on the Role of BASILICA to Reduce the Risk of Coronary Obstruction During VIV Procedures

Perspectives on Infarct Size as a Surrogate in STEMI

TAVR for Bioprosthetic Aortic Valve Failure 1: "To Crack or Not to Crack" — Case Presentation and Update on the Role of Fracturing Bioprosthetic Valves During VIV Procedures

Industry View on Controlled Trials for Heart Failure and Shock Devices

ARC Initiative for Heart Failure and Shock: HF ARC, Shock ARC, and More

SCOPE I: Acurate Neo Comes Up Short for Severe Aortic Stenosis

Devices for Heart Failure: FDA Perspectives on Trial Designs and Endpoints

Learning Curve Exists for MitraClip, Volume-Outcomes Data Hint

Role of Heart Failure Specialist in the Post-COAPT World

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content